Stockreport

Heron Therapeutics: Generic Competition And HTX-011 Approval May Put Pressure On Share Price [Seeking Alpha]

Heron Therapeutics, Inc.  (HRTX) 
Last heron therapeutics, inc. earnings: 3/2 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: herontherapeutics.gcs-web.com/investor-home
PDF Summary Heron Therapeutics' 2 commercialised drugs for the treatment of acute and delayed nausea and vomiting associated with types of chemotherapy are under pressure fr [Read more]